Impact of overactive bladder on women in the United States:results of a national survey

References

• Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003;61:37–49
   PubMed Web of Science ®Google Scholar
• Milsom I, Stewart W, Thuroff J. The prevalence of overactive bladder. Am J Manag Care 2000;6(Suppl 11):S565–S572
   Google Scholar
• Milsom I, Abrams P, Cardozo L, et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. Br J Urol Int 2001;87:760–6
   Google Scholar
• Nygaard IE, Lemke JH. Urinary incontinence in rural older women: prevalence, incidence and remission. J Am Geriatr Soc 1996;44:1049–54
   PubMed Web of Science ®Google Scholar
• Samuelsson E, Victor A, Tibblin G. A population study of urinary incontinence and nocturia among women aged 20– 59 years: prevalence, well-being and wish for treatment. Acta Obstet Gynecol Scand 1997;76: 74–80
   Google Scholar
• Stewart WF, Van Rooyan JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003;20:327–36
   PubMed Web of Science ®Google Scholar
• Wein AJ, Rovner ES. Definition and epidemiology of overactive bladder. Urology 2002;60(Suppl 1):7–12
   PubMed Web of Science ®Google Scholar
• Brown JS. Epidemiology and changing demographics of overactive bladder: a focus on the postmenopausal woman. Geriatrics 2002;57(Suppl 1):6–12
   PubMedGoogle Scholar
• Shah D, Badlani G. Treatment of overactive bladder and incontinence in the elderly. Rev Urol 2002;4(Suppl 4):s38–s43
   PubMedGoogle Scholar
• Ouslander JG. Geriatric considerations in the diagnosis and management of overactive bladder. Urology 2002;60:50–5
   PubMed Web of Science ®Google Scholar
• DuBeau CE. Interpreting the effect of common medical conditions on voiding dysfunction in the elderly. Urol Clin North Am 1996;23:11–8
   PubMed Web of Science ®Google Scholar
• Brown JS, Seeley DG, Fong J, et al. Urinary incontinence in older women: who is at risk? Obstet Gynecol 1996;87:715–21
   PubMed Web of Science ®Google Scholar
• Freeman RM, McPherson FM, Baxby K. Psychological features of women with idiopathic detrusor instability. Urol Int 1985;40:257–9
   Google Scholar
• Yarnell JW, Voyle GJ, Sweetnam PM, et al. Factors associated with urinary incontinence in women. J Epidemiol Community Health 1982;36:58–63
   PubMed Web of Science ®Google Scholar
• Sampselle CM, Wyman JF, Thomas KK, et al. Continence for women: a test of AWHONN’s evidence-based protocol in clinical practice [Association of Women’s Health Obstetric and Neonatal Nurses]. J Obstet Gynecol Neonatal Nurs 2000;29:18–26
   PubMedGoogle Scholar
• Lam GW, Foldspang A, Elving LB, Mommsen S. Social context, social abstention, and problem recognition correlated with adult female urinary incontinence. Dan Med Bull 1992;39:565–70
   PubMed Web of Science ®Google Scholar
• Smoger SH, Felice TL, Kloecker GH. Urinary incontinence among male veterans receiving care in primary care clinics. Ann Intern Med 2000;132:547–51
   Google Scholar
• Van Oyen H, Van Oyen P. Urinary incontinence in Belgium: prevalence, correlates and psychosocial consequences. Acta Clin Belg 2002;57:207–18
   PubMed Web of Science ®Google Scholar
• Bogner HR, Gallo JJ, Sammel MD, et al. Urinary incontinence and psychological distress in community-dwelling older adults. J Am Geriatr Soc 2002;50:489–95
   PubMed Web of Science ®Google Scholar
• Kinchen KS, Burgio K, Diokno A, et al. Factors associated with women’s decisions to seek treatment for urinary incontinence. J Women’s Health 2003;12:687–98
   PubMed Web of Science ®Google Scholar
• Ricci JA, Baggish JS, Hunt TL, et al. Coping strategies and health care-seeking behavior in a US national sample of adults with symptoms suggestive of overactive bladder. Clin Ther 2001;23:1245–59
   PubMed Web of Science ®Google Scholar
• Palmer MH, Fitzgerald S. Urinary incontinence in working women: a comparison study. J Women’s Health 2002;11: 879–88
   PubMed Web of Science ®Google Scholar
• Kelleher CJ, Cardozo L, Chapple CR, et al. Improved quality of life in patients with overactive bladder symptoms treated with solifenacin. Br J Urol Int 2005;95:81–5
   Google Scholar
• Coyne KS, Payne C, Bhattacharyya SK, et al. The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey. Value Health 2004;7:455–63
   PubMed Web of Science ®Google Scholar
• Lucente V, Goldberg R, Davila GW, et al. Impact of transdermal oxybutynin on the quality of life in OAB patients: results from the MATRIX study. Poster presented at: American College of Obstetricians and Gynecologists (ACOG) 54th Annual Clinical Meeting; May 6–10, 2006; Washington, DC
   Google Scholar
• Avery K, Donovan J, Peters TJ, et al. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn 2004;23:322–30
   PubMed Web of Science ®Google Scholar
• Hing E, Poe G, Euller R. The effect of methodological differences in two surveys’ estimates of the percentage of employers sponsoring health insurance. Inquiry 1999;36:212–20
   Google Scholar
• Whitmore RW, Byron MZ, Clayton CA, et al. Sampling design, response rates, and analysis weights for the National Human Exposure Assessment Survey (NHEXAS) in EPA region 5. J Expo Anal Environ Epidemiol 1999;9:369–80
   PubMedGoogle Scholar
• Sandman D, Trauring A. Survey of adult women with over-active bladder. New York (NY): Harris Interactive Inc; January 2003
   Google Scholar
• Finkelstein MM. Medical conditions, medications, and urinary incontinence: analysis of a population-based survey. Can Fam Physician 2002;48:96–101
   PubMed Web of Science ®Google Scholar
• Buchsbaum GM, Chin M, Glantz C, Guzick D. Prevalence of urinary incontinence and associated risk factors in a cohort of nuns. Obstet Gynecol 2002;100:226–9
   PubMed Web of Science ®Google Scholar
• Hannestad YS, Rortveit G, Hunskaar S. Help-seeking and associated factors in female urinary incontinence [The Norwegian EPINCONT Study: Epidemiology of Incontinence in the County of Nord-Trondelag]. Scand J Prim Health Care 2002;20:102–7
   Google Scholar
• MacKay K, Hemmett L. Needs assessment of women with urinary incontinence in a district health authority. Br J Gen Pract 2001;51:801–4
   PubMed Web of Science ®Google Scholar
• Wenger NS, Solomon DH, Roth CP, et al. The quality of medical care provided to vulnerable community-dwelling older patients. Ann Intern Med 2003;139:740–7
   PubMed Web of Science ®Google Scholar
• Herbison P, Hay-Smith J, Ellis G, et al. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. Br Med J 2003;326:841–4
   PubMed Web of Science ®Google Scholar
• Diokno AC, Appell RA, Sand PK, et al. Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. Mayo Clin Proc 2003;78:687–95
   PubMed Web of Science ®Google Scholar
• Abrams P, Freeman R, Anderstrom C, Mattiasson A. Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder. Br J Urol 1998;81:801–10
   PubMedGoogle Scholar
• Harvey MA, Baker K, Wells GA. Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: a meta-analysis. Am J Obstet Gynecol 2001;185:56–61
   Google Scholar
• Appell RA, Sand P, Dmochowski R, et al. Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT study. Mayo Clin Proc 2001;76:358–63
   PubMed Web of Science ®Google Scholar
• Lawrence M, Guay DR, Benson SR, Anderson MJ. Immediate-release oxybutynin versus tolterodine in detrusor overactivity: a population analysis. Pharmacotherapy 2000;20:470–5
   PubMed Web of Science ®Google Scholar
• Dmochowski R, Kell S, Staskin D. Oxybutynin chloride: alterations in drug delivery and improved therapeutic index. Expert Opin Pharmacother 2002;3:443–54
   Google Scholar
• Gupta SK, Sathyan G, Lindemulder EA, et al. Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose–side effect relationships. Clin Pharmacol Ther 1999;65: 672–84
   PubMed Web of Science ®Google Scholar
• Kershen RT, Hsieh M. Preview of new drugs for overactive bladder and incontinence: darifenacin, solifenacin, trospium, and duloxetine. Curr Urol Rep 2004;5:359–67
   PubMedGoogle Scholar
• Anderson RU, Mobley D, Blank B, et al. Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence: OROS oxybutynin study group. J Urol 1999;161:1809–12
   PubMed Web of Science ®Google Scholar
• Dmochowski RR, Nitti V, Staskin D, et al. Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials. World J Urol 2005;23:263–70
   PubMed Web of Science ®Google Scholar
• Murray M, Swan AV, Kiryluk S, Clarke GC. The Hawthorne effect in the measurement of adolescent smoking. J Epidemiol Community Health 1988;42:304–6
   PubMed Web of Science ®Google Scholar
• Siracusano S, Pregazzi R, d’Aloia G, et al. Prevalence of urinary incontinence in young and middle-aged women in an Italian urban area. Eur J Obstet Gynecol Reprod Biol 2003;107: 201–14
   Google Scholar
• Peyrat L, Haillot O, Bruyere F, et al. Prevalence and risk factors of urinary incontinence in young women. Prog Urol 2002;12:52–9
   PubMed Web of Science ®Google Scholar
• Dallosso HM, McGrother CW, Matthews RJ, et al. The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women. Br J Urol Int 2003;92:69–77
   Google Scholar
• Dmochowski RR, Parker RL, Melkonian R. Effects of prior therapy on health-related quality of life following treatment with transdermal oxybutynin. Poster presented at: American Urogynecologic Society 27th Annual Scientific Meeting; October 19–21, 2006; Palm Springs, California
   Google Scholar